ABG-WTT Global Life Science Capital Partners’s Rapid Micro Biosystems RPID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.2M Hold
1,848,296
34.13% 2
2025
Q4
$5.36M Hold
1,848,296
35.62% 2
2025
Q3
$6.17M Hold
1,848,296
33.06% 2
2025
Q2
$6.38M Hold
1,848,296
23.83% 2
2025
Q1
$4.88M Buy
1,848,296
+810,000
+78% +$1.85M 12.73% 3
2024
Q4
$934K Hold
1,038,296
2.14% 3
2024
Q3
$924K Hold
1,038,296
4.59% 2
2024
Q2
$685K Hold
1,038,296
2.29% 2
2024
Q1
$768K Hold
1,038,296
1.85% 2
2023
Q4
$768K Hold
1,038,296
1.5% 3
2023
Q3
$1.12M Hold
1,038,296
5.38% 3
2023
Q2
$1.04M Hold
1,038,296
18.84% 2
2023
Q1
$1.36M Hold
1,038,296
21.45% 2
2022
Q4
$1.17M Hold
1,038,296
18.96% 2
2022
Q3
$3.35M Hold
1,038,296
20.94% 2
2022
Q2
$4.46M Hold
1,038,296
15.75% 2
2022
Q1
$7.05M Buy
+1,038,296
New +$7.65M 57.23% 1

Other funds holding RPID

ABG-WTT Global Life Science Capital Partners's RPID Position: Q1 2026 in Review

ABG-WTT Global Life Science Capital Partners held its Rapid Micro Biosystems (RPID) position steady in Q1 2026 at 1,848,296 shares worth $4.2M. The position accounts for 34.13% of the portfolio, ranked #2.

ABG-WTT Global Life Science Capital Partners first reported a position in RPID in Q1 2022 and has held it in 17 quarters since. The position peaked at $7.05M in Q1 2022. 46 funds tracked by Wall St. Rank hold RPID as of Q1 2026.

  • ABG-WTT Global Life Science Capital Partners held 1,848,296 shares of Rapid Micro Biosystems worth $4.2M as of Q1 2026.
  • ABG-WTT Global Life Science Capital Partners left its Rapid Micro Biosystems share count unchanged in Q1 2026.
  • Rapid Micro Biosystems made up 34.13% of ABG-WTT Global Life Science Capital Partners's portfolio in Q1 2026, its #2 holding.
  • ABG-WTT Global Life Science Capital Partners first reported a position in Rapid Micro Biosystems in Q1 2022 and has held it in 17 quarters since.
  • ABG-WTT Global Life Science Capital Partners's Rapid Micro Biosystems position peaked at $7.05M in Q1 2022.
  • 46 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2026.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q1 2026, filed 18 May 2026.